Usefulness of corticosteroids as first-line therapy in patients with acute severe autoimmune
hepatitis Usefulness of corticosteroids as first-line therapy in patients with acute severe …

Acute and fulminant forms of autoimmune hepatitis were recognized by the International
Autoimmune Hepatitis Group in 1992 when it codified diagnostic criteria and waived the …

Aims The definition of original acute severe autoimmune hepatitis (AS‐AIH) is unclear.
However, its rapid recognition and early treatment is potentially life‐saving. Therefore, we …

We read with interest the review by Rahim et al.,(1) in which they gave an elegant summary
of the role, predictors, and optimal timing of corticosteroids and liver transplantation (LT) in …

Acute severe presentations of autoimmune hepatitis (AIH) represent a challenge for the
transplant community. As a disease, it is poorly characterized, and there is a weak evidence …

Immunosuppressive therapy, and particularly corticosteroids with or without azathioprine,
can achieve a remission in more than 80% of patients with autoimmune hepatitis (AIH). By …

Multiple controlled trials have established the efficacy of corticosteroids in the treatment of
autoimmune hepatitis [1–3]. Prednisone alone or a lower dose in combination with …

A retrospective cohort study involving 29 Japanese patients with autoimmune hepatitis (AIH)
was performed to clarify factors that predict the efficacy of prednisolone and the occurrence …

BACKGROUND Corticosteroids are used to induce remission in auto-immune hepatitis.
They are not universally effective; therefore, alternative treatments are needed. In this study …

Autoimmune hepatitis commonly relapses after corticosteroid therapy, and long‐term
management strategies have been proposed based on the premise that repeated relapses …